This site is intended for U.S. healthcare professionals.
Making your patients’ support needs a priority. Together.
At Pfizer Oncology Together, patient support is at the core of everything we do. We’ve gathered resources and developed tools to help patients and their loved ones throughout INLYTA® (axitinib) treatment. From helping to identify financial assistance options to connecting patients to resources for emotional support, our patients’ needs are our priority.
Pfizer Oncology Together can help patients understand their insurance benefits and connect them with financial assistance resources (if needed), regardless of their insurance coverage.
Resources for eligible patients with commercial, private, employer, or state health insurance marketplace coverage:
Co-pay assistance: Eligible, commercially insured patients may pay as little as $0 per month for INLYTA. Limits, terms, and conditions apply.* Patients may receive up to $25,000 per product in savings annually. There are no income requirements, forms, or faxing to enroll
*Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $25,000 per product in savings annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. For full Terms and Conditions, please see PfizerOncologyTogether.com/terms. For any questions, please call 1-877-744-5675, visit PfizerOncologyTogether.com/terms or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.
MEDICARE/GOVERNMENT INSURED
Help identifying resources for patients with Medicare/Medicare Part D, Medicaid, and other government insurance plans who express a financial need and may be eligible:
UNINSURED
Help identifying resources for patients without any form of healthcare coverage who may be eligible:
†The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc. with distinct legal restrictions.
‡The Pfizer Savings Program is not health insurance. For more information, call the toll-free number 1-877-744-5675. There are no membership fees to participate in this program. Estimated savings are 50% and depend on such factors as the particular drug purchased, amount purchased, and the pharmacy where purchased.
Access & Reimbursement Assistance
If patients need access or reimbursement assistance, Pfizer Oncology Together is here to help with:
Personalized Patient Support
When your patients and their caregivers need support for their day-to-day challenges with treatment, we want to be a place they can turn to for help. At Pfizer Oncology Together, our Care Champions, who have social work experience, can connect patients prescribed INLYTA to resources that may help with some of their daily needs.§
Call 1-877-744-5675 (Monday-Friday 8 AM-8 PM ET)
§Some services are provided through third-party organizations that operate independently and are not controlled by Pfizer. Availability of services and eligibility requirements are determined solely by these organizations.
Pfizer Oncology Together Co-Pay Savings Program
Terms & Conditions
By using this co-pay card or by mailing in this rebate, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:
INLYTA® (axitinib) in combination with pembrolizumab is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
Please see full Prescribing Information.
OK. We'll need you to sign in before we can determine if you are aligned with a sales representative.
If you select 'Yes', you will be required to enter your username and password in the sign-in form that will appear over this window.
Would you like to sign in now?